Anavex Life Sciences Provides an Update on Rett Syndrome Program
Go back to Anavex Life Sciences Provides an Update on Rett Syndrome Program| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 2.56 -0.02 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.58 | 52 Week High | $8.30 | |||
| Open | $2.57 | 52 Week Low | $2.43 | |||
| Day High | $2.68 | P/E | N/A | |||
| Day Low | $2.55 | EPS | $-0.22 | |||
| Volume | 638,615 | |||||
| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 2.56 -0.02 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.58 | 52 Week High | $8.30 | |||
| Open | $2.57 | 52 Week Low | $2.43 | |||
| Day High | $2.68 | P/E | N/A | |||
| Day Low | $2.55 | EPS | $-0.22 | |||
| Volume | 638,615 | |||||

